Albemarle Corporation delivered strong fourth quarter results with net sales up 16% to $1.4 billion and adjusted EBITDA increasing 7% to $269 million, driven by volume gains in Energy Storage and Ketjen. The company reported a net loss of $414 million, primarily due to tax-related items and asset write-downs, but adjusted diluted loss per share improved significantly.

Albemarle’s third quarter 2025 performance showed operational resilience with adjusted EBITDA growth and strategic cost improvements, despite headwinds from falling lithium prices and a goodwill impairment charge.

Albemarle delivered strong second-quarter results, with net sales of $1.3 billion and a net income of $22.9 million, a substantial improvement from a net loss in the prior-year quarter. The company achieved positive free cash flow for the first half of 2025 and expects to maintain this for the full year, driven by cost savings and operational excellence. Energy Storage volumes increased by 15%, while Specialties saw a 6% volume increase.

Albemarle delivered $1.08B in revenue and $41M in net income in Q1 2025. The company faced lower pricing in its Energy Storage segment but benefited from strong performance in Specialties and Ketjen. It maintained its FY2025 outlook despite macro headwinds and market volatility.

Albemarle reported a sharp revenue decline of 47.7% YoY in Q4 2024 due to lower lithium prices and volumes. Despite this, cost reductions and tax benefits led to a return to profitability, with net income of $75.3M. Adjusted EPS remained negative but showed significant improvement.

Albemarle Corporation reported third-quarter 2024 net sales of $1.4 billion, a 41% year-over-year decline. The company experienced a net loss of ($1.1) billion, or ($9.45) per diluted share, including pre-tax charges of $861 million. Adjusted EBITDA was $211 million, with Specialties and Ketjen showing significant year-over-year growth.

Albemarle Corporation reported a net sales of $1.4 billion, a net loss of $188 million, and an adjusted EPS of $0.04. The company delivered over $150 million in productivity benefits and is on track to exceed its full-year restructuring and productivity target by 50%.

Albemarle's first quarter 2024 net sales reached $1.4 billion, driven by Energy Storage volume growth. Net income was $2 million, with adjusted diluted EPS at $0.26 and adjusted EBITDA at $291 million. The company is on track to deliver over $280 million in productivity benefits in 2024, with over $90 million achieved in Q1.

Albemarle Corporation reported a decrease in net sales for Q4 2023, primarily due to lower lithium market pricing, despite increased volumes in Energy Storage and Ketjen. The company experienced a net loss, driven by lower lithium market prices and a significant LCM charge.

Albemarle Corporation reported a 10% increase in net sales for the third quarter of 2023, reaching $2.3 billion. This growth was primarily driven by higher volumes in the Energy Storage business. The company's net income was $302.5 million, or $2.57 per diluted share, and adjusted diluted EPS was $2.74. Albemarle is on track to achieve more than $170 million in productivity benefits in 2023.

Albemarle Corporation reported a net sales increase of 60% for the second quarter of 2023, reaching $2.4 billion. Net income also increased by 60% to $650.0 million, or $5.52 per diluted share. Adjusted diluted EPS increased by 112% to $7.33, and adjusted EBITDA increased by 69% to $1.0 billion.

Albemarle Corporation reported a strong first quarter in 2023, with net sales increasing by 129% to $2.6 billion and net income increasing by 389% to $1.2 billion. Adjusted diluted EPS increased by 334% to $10.32, and adjusted EBITDA increased by 269% to $1.6 billion. The company has adjusted its 2023 guidance to reflect current lithium market pricing.

Albemarle Corporation reported a significant increase in net sales for Q4 2022, nearly tripling compared to the prior-year quarter, driven by higher lithium prices and increased volumes. Net income also saw a substantial rise, reaching $1.1 billion, while adjusted EBITDA increased by 444%.

Albemarle Corporation reported a net sales increase of 152% for the third quarter of 2022, reaching $2.1 billion. The company's adjusted EBITDA increased by 447% to $1.2 billion, and net income attributable to Albemarle Corporation was $897.2 million, or $7.61 per diluted share.

Albemarle Corporation announced strong second-quarter results with net sales of $1.48 billion, a 91% increase year-over-year, and net income of $406.8 million. The company raised its full-year 2022 guidance due to strong demand and pricing trends, particularly in Lithium and Bromine.

Albemarle Corporation announced strong first quarter results with net sales of $1.13 billion, a 36% increase year-over-year. The company raised its full year 2022 guidance due to increased prices in the Lithium and Bromine businesses.

Albemarle Corporation reported Q4 2021 results with net sales increasing by 2% to $894 million. The company experienced a net loss of $3.8 million, but adjusted EBITDA increased by 3% to $229 million. The company is raising its 2022 outlook based on favorable market conditions.

Albemarle Corporation announced its Q3 2021 results, featuring a net sales increase of 11% to $830.6 million. Despite supply chain challenges and increased raw material costs, the company delivered solid revenue and adjusted EBITDA growth. The company also increased its full-year 2021 guidance based on strong third-quarter performance.

Albemarle's Q2 2021 net sales increased by 1% to $773.9 million. Net income attributable to Albemarle Corporation was $424.6 million, or $3.62 per diluted share, including a gain on the sale of Fine Chemistry Services (FCS) business. Adjusted diluted EPS was $0.89, an increase of 4%. Adjusted EBITDA was $194.6 million, an increase of 5%.

Albemarle Corporation announced its first quarter results with a 12% increase in net sales and a 17% increase in adjusted EBITDA. The company is progressing with its lithium expansion projects and expects to start approving Wave 3 expansion projects during the second quarter.

Albemarle's Q4 2020 adjusted EBITDA exceeded expectations, driven by the hard work and diligence of the operating teams. The company is accelerating high-return growth in its Lithium and Bromine businesses while maintaining focus on operational discipline.

Albemarle's Q3 2020 net sales were $747 million, a 15% decrease year-over-year. Net income was $98 million, or $0.92 per diluted share, with adjusted diluted EPS of $1.09. Adjusted EBITDA was $216 million, a 15% decrease year-over-year but exceeding the high-end of the Q3 2020 outlook by 14%. The company expects approximately $80 million of sustainable cost savings to be achieved in 2020.

Albemarle Corporation reported a net sales of $764 million and a net income of $86 million for Q2 2020. The company's results were in line with its Q2 2020 outlook, despite a 14% decrease in net sales compared to the previous year. The company is focusing on operational discipline and investing in its Lithium business.

Albemarle's first quarter 2020 results showed net sales of $739 million and a net income of $107 million, or $1.01 per diluted share. Adjusted diluted EPS was $1.00. The company is implementing cost-saving measures and managing cash flow due to the uncertain economic impact of the global pandemic.

Albemarle Corporation reported an increase in net sales and adjusted diluted EPS for Q4 2019, but diluted EPS decreased. The company completed the acquisition of a 60% ownership in the Wodgina spodumene mine and formed a joint venture. They also issued notes to repay debt and fund the acquisition.